KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Evolent Health (EVH) Return on Equity (2016 - 2026)

Evolent Health has reported Return on Equity over the past 11 years, most recently at 0.01% for Q4 2025.

  • For Q4 2025, Return on Equity fell 1.0% year-over-year to 0.01%; the TTM value through Dec 2025 reached 0.01%, down 1.0%, while the annual FY2025 figure was 0.01%, N/A changed from the prior year.
  • Return on Equity for Q4 2025 was 0.01% at Evolent Health, down from 0.0% in the prior quarter.
  • Over five years, Return on Equity peaked at 0.0% in Q4 2022 and troughed at 0.01% in Q4 2025.
  • A 5-year average of 0.0% and a median of 0.0% in 2023 define the central range for Return on Equity.
  • Biggest five-year swings in Return on Equity: changed 0bps in 2021 and later fell -1bps in 2025.
  • Year by year, Return on Equity stood at 0.0% in 2021, then soared by 95bps to 0.0% in 2022, then tumbled by -3322bps to 0.0% in 2023, then plummeted by -227bps to 0.0% in 2024, then tumbled by -1306bps to 0.01% in 2025.
  • Business Quant data shows Return on Equity for EVH at 0.01% in Q4 2025, 0.0% in Q3 2025, and 0.0% in Q2 2025.